register free | resend password


Next Generation Sequencing (NGS) Industry Insights | Companies like Illumina are increasing their installation base by providing sequencing services in different emerging countries

The global Next Generation Sequencing market size was valued at USD 8.49 billion in 2018 and is expected to register a CAGR of 12.78% over the forecast period. Introduction of advanced and rapid sequencing technologies for clinical processes is expected to drive the market.

ID: 1552124
recent pressrelease next pressrelease

(businesspress24) - The global next generation sequencing market is expected to reach USD 19.70 billion by 2025 registering a CAGR of 12.78%, according to a new report by Grand View Research, Inc. Growing application of NGS methodologies due to rising number of strategic developments initiated by the market participants is one of the key drivers of the market. These novel strategies mark the presence of intense competition between the key firms. Companies are further increasing their installation base by providing sequencing services in different emerging countries. For instance, in April 2018, Illumina entered into a partnership with Loxo Oncology for the development of Illumina TruSight Tumor 170 NGS test as a companion diagnostic for Loxo Oncology

Similarly, in March 2018, PierianDx partnered with cancer genetics to offer NGS-based tests for oncology precision medicine. NGS technologies experience significant growth due to rapid automation in the pre-sequencing protocols and advancements in clinical diagnosis and disease testing. Wide application of this technique in oncology, reproductive screening, infectious disease, noninvasive prenatal testing and pharmacogenomics is also expected to positively impact the market growth. Reduced costs of genetic sequencing has also significantly enhanced the adoption of these technologies.
Reduced installation costs of NGS platforms and easy availability of proteomic and genomic data has also resulted in an increased demand, thereby propelling the market development.

Further key findings from the study suggest:
& related products account for the dominant market share due to the presence of sequencing platforms and instruments required for clinical applications


&A are some of the key strategies adopted by these companies, for instance, Illumina acquired Edico Genome to improve the overall efficiency of NGS solutions provided by Illumina



More information:
http://snip.ly/fipxzz



Keywords (optional):

biotech, biotech-industry, biotechnology, next-generation-sequencing, next-generation-sequencing-industry, next-generation-sequencing-market, ngs, sequencing, tech, technology,



Company information / Profile:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

PressRelease by

Requests:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales(at)grandviewresearch.com
For More Information: www.grandviewresearch.com



PressContact / Agency:



published by: HexaResearch
print pressrelease  send to a friend  

Date: 09/12/2019 - 08:45
Language: English
News-ID 1552124
Character count: 3661
Kontakt-Informationen:
Firma: Grand View Research, Inc.
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: San Francisco
Telefon: 1-888- 202-9519

Meldungsart: Financial
Versandart: send
Freigabedatum: 12.09.2019
Comments:



Number of hits: 790

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 436
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 214


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.